Well be there to answer your questions, support your progress, and celebrate your success along the way
Physician-prescribed topical GHK-Cu has one of the best safety profiles in the peptide skincare category, supported by decades of cosmetic and clinical use
Comparison of biochemical indicators At 12 and 20 weeks of treatment, the semaglutide-intensified treatment group demonstrated significant reductions in fasting plasma glucose, fasting insulin, and HOMA-IR compared to the standard treatment group, with significant differences ( P 0.05) [Table 1]
Blood Cancer 60 (7), 11081112
Autoimmune Conditions, Insulin Resistance & Arthritis: By supporting gut health, these peptides may help decrease systemic inflammation, contributing to improved metabolic and immune responses